Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01298492 · ClinicalTrials.gov registry record · Phase 2
A Study To Monitor Long-Term Treatment With PF-00547659
A Phase 2 study of Crohn's Disease, sponsored by Shire.
- Completed
- Registry status
- Phase 2
- Development phase
- 268
- Enrollment target
- 20
- Study locations
NCT01298492 is a Phase 2 study of Crohn's Disease that has completed, run by Shire. The registered enrollment target is 268 participants, below the 2,392-participant average among 105 other Crohn's Disease trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 7 states.
The verdict
NCT01298492, a Phase 2 study of Crohn's Disease, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 268 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study provides open-label drug to eligible patients who have completed a prior study of PF-00547659. The primary endpoint for this study is long-term safety.
Conditions Studied
Interventions
- DRUG PF-00547659
Study Locations (20)
Florida
- Florida Center for Gastroenterology - Largo
- Sylvester Comprehensive Cancer Center - Miami
- University of Miami Crohn's and Colitis Center - Miami
- University of Miami Hospital and Clinic (IP Shipment Only) - Miami
- University of Miami Hospital and Clinic - Miami
- University of Miami Hospital - Miami
- Citrus Ambulatory Surgery Center - Orlando
- Internal Medicine Specialists - Orlando
California
- UCSD Medical Center - Thorton Hospital - La Jolla
- Community Clinical Trials - Orange
- GastroDiagnostics - Orange
Colorado
- Clinical Research of the Rockies - Lafayette
- Rmga - Rmcr - Thornton
- Rocky Mountain Gastroenterology Associates - Thornton
Iowa
- Heartland Medical Research, Inc. - Clive
- Iowa Digestive Disease Center - Clive
- Iowa Endoscopy Center (Colonoscopy Only) - Clive
District of Columbia
- MGG Group Co., Inc. - Washington D.C.
Maryland
- Metropolitan Gastroenterology Group, PC - Chevy Chase Clinical Research - Chevy Chase
Massachusetts
- UMass Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2011-07-01 |
| Est. Completion | 2016-07-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01298492
The ClinicalTrials.gov registry entry for NCT01298492 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,392-participant average among 105 other Crohn's Disease trials with a reported enrollment target (89% lower). The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Crohn's Disease appearing as the primary indexed condition, and to 1 intervention - of which PF-00547659 is the first listed.
NCT01298492 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT01298492 about?
NCT01298492 is a clinical study titled "A Study To Monitor Long-Term Treatment With PF-00547659". This study provides open-label drug to eligible patients who have completed a prior study of PF-00547659. The primary endpoint for this study is long-term safety.
What is the current status of trial NCT01298492?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 268 participants. The study started on 2011-07-01. Estimated completion is 2016-07-27.
What conditions does trial NCT01298492 study?
This clinical trial studies the following conditions: Crohn's Disease.
What interventions are being tested in trial NCT01298492?
The interventions under investigation include: PF-00547659 (DRUG).
Who is sponsoring clinical trial NCT01298492?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01298492 being conducted?
This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RECRUITING · Phase 2
-
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
RECRUITING · Phase 2
-
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RECRUITING · Phase 2
-
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
RECRUITING · Phase 2
-
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
RECRUITING · Phase 2
-
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.